Marty, my $27 price was based on DCVax-L being approved by the four regulators that conducted the trial. That would have DCVax-L available in all of Europe, Canada, and the US. What price would you predict if this were true and sales were coming in from all these countries for GBM patients alone.
How long do you think it will take if NWBO announces that it has international approval of the EDEN unit, an agreement with Advent and CRL, or some other company, to produce and handle the vaccine worldwide, and has submitted to the other three regulators.
Gary
Market Data 
Markets 
AI
